FDA Drug Approval, N012122, GLUCAGON
FDA Drug Approval, N012122, GLUCAGON
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 012122
Company: LILLY
Drug Name: GLUCAGON
Active Ingredients: GLUCAGON HYDROCHLORIDE
Strength: EQ 10MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 11/14/1960
Marketing Status: Discontinued
Submission Classification: Type 1 - New Molecular Entity
Company: LILLY
Drug Name: GLUCAGON
Active Ingredients: GLUCAGON HYDROCHLORIDE
Strength: EQ 10MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 11/14/1960
Marketing Status: Discontinued
Submission Classification: Type 1 - New Molecular Entity
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details